Elevated Creatine Kinase in Mucolipidosis Type IV: Investigating an Atypical Manifestation and Its Clinical Complications. [PDF]
Alsahlawi Z +7 more
europepmc +1 more source
Ploidy‐dependent modulation of DNA replication kinetics in Xenopus
Using an interspecies replication system with Xenopus frog species of different ploidy levels, we investigated how DNA replication adapts to polyploidization. While replication was slower in tetraploid than in diploid nuclei, dodecaploid nuclei unexpectedly replicated faster than tetraploid nuclei. Our findings show that increasing genome size does not
Hemalatha Narassimprakash +4 more
wiley +1 more source
Elevated Creatine Kinase as a Marker for Aggressive GI Malignancy. [PDF]
Vasireddy R +3 more
europepmc +1 more source
Energetic dysregulations in psychotic disorders: Targets for new therapeutics
The present review synthesizes literature documenting aberrant energy production and use, specifically related to mitochondrial and redox dysregulation, in psychotic disorders. Findings from different levels of investigation—genetic, cellular, and in vivo imaging—converge on aberrant energy metabolism as a hallmark of psychotic disorders.
Jacey Anderson +10 more
wiley +1 more source
Marked Asymptomatic Creatine Kinase Elevation With Preserved Renal Function Identified Through Protocol-Driven Monitoring in a Clinical Trial Participant: A Case Report. [PDF]
Anasobi RT, Parmar T, Stewart O.
europepmc +1 more source
Hydrothermal origin of metabolic phosphorylation
Serpentinizing hydrothermal vents are candidate sites for biochemical origins. They generate extremely reducing conditions, depositing phosphite (HPO32−) and transition metals, including palladium, in the native (zero‐valent) state. Schlikker et al.
Manon L. Schlikker +5 more
wiley +1 more source
Multi-ancestry genome-wide association study of serum creatine kinase implicates myopathy genes and muscle pathways. [PDF]
Chen G +7 more
europepmc +1 more source
A randomized phase 2 trial of socrodeucitinib in moderate‐to‐severe plaque psoriasis
In moderate‐to‐severe plaque psoriasis, socrodeucitinib (6 mg/12 mg) significantly outperformed placebo at week 12: PASI 75 response rates 28.6%/72.1% vs. 7.5%. Meanwhile, socrodeucitinib illustrated a favourable safety and tolerability profile, warranting further study.
Ling Han +24 more
wiley +1 more source
Idiopathic Inflammatory Myopathy With Normal Creatine Kinase Levels in an Elderly Patient: A Diagnostic Challenge. [PDF]
Chilakuluri P +4 more
europepmc +1 more source

